Abstract:SESSION TITLE: Tuesday Abstract Posters SESSION TYPE: Original Investigation Posters PRESENTED ON: 10/22/2019 01:00 PM - 02:00 PM PURPOSE: The aim of the study is to determine the association of impact factors and predictive biomarkers with high VTE risk in hospitalized patients with AECOPD and to provide the theoretical proof for the early prevention of VTE with low molecular weight heparin (LMWH) based on the prethrombotic state (PTS) of the cohort. METHODS: Hospitalized patients with AECOPD were enrolled prospectively from April 2018 to April 2019. Demographic data including gender, age, smoking history, chronic diseases, arterial blood gas and other clinical data were recorded. These patients were divided into the low-risk group and high-risk group using Padua risk assessment score (PRAS). The high-risk group was further subdivided into anticoagulation group and non-anticoagulation group depending on the use of low molecular weight heparin (LMWH). The plasma levels of new coagulation-fibrinolytic biomarkers such as thrombomodulin (TM), thrombin-antithrombin complex (TAT), plasminogen-α2 plasminogen inhibitor complex (PIC) and tissue-type plasminogen activator-plasminogen activator inhibitor complex (t-PAI-C) as well as routine coagulation-fibrinolysis parameters were measured on admission (D0), the third day (D3) and seventh day (D7) after admission respectively. Same serum samples were also collected and measured in healthy individuals from the physical examination center as a control group. The levels of coagulative parameters and other clinical indices were measured and compared among the groups.The receiver-operating characteristic (ROC) curves of these indices were generated, and the area under the curve (AUC) was calculated. The predictive values of the selected potential parameters were examined in binary regression analysis. RESULTS: A total of 100 patients with AECOPD (48 cases in the low-risk group and 52 cases in the high-risk group) and 20 controls were enrolled in our study. Non-invasive ventilation treatment, deep vein puncture/catheterization, bed rest/immobilized > 3 days, pulmonary heart disease, type-II respiratory failure were more common in the high-risk group. The duration of hospitalization in the high-risk group was significantly longer than that in the low-risk group (P< 0.05). The levels of white blood cell (WBC), neutrophil (NEU), TM, TAT, PIC, t-PAI-C, plasma prothrombin time (PT), activated partial thromboplastin time (APTT), fibrinogen concentration (FIB), D-Dimer (DD), and fibrinogen degradation product (FDP) on D0 were higher in patients with AECOPD than the cohort in control group (p<0.05). CONCLUSIONS: Non-invasive ventilation treatment, deep vein puncture/catheterization, bed rest/immobilization > 3 days, pulmonary & heart disease, type-II respiratory failure and duration of hospitalization are considered to be associated with higher risk of VTE. The levels of PaCO2, NEU, and TT may serve as predictors for higher risk of VTE and could guide treatment strategies with LMWH to prevent VTE in these patients. CLINICAL IMPLICATIONS: The dysfunction of the blood coagulation-fibrinolysis system is a salient characteristic of VTE requiring optimized management depending on its severity. Therefore, finding suitable biomarkers that could predict the onset of VTE could be helpful. DISCLOSURES: No relevant relationships by aamer Chughtai, source=Web Response no disclosure on file for XIAO GAN; No relevant relationships by Lu Guo, source=Web Response no disclosure on file for YICEN HAN; no disclosure on file for Yanxin Li; no disclosure on file for Jingyan Liu; no disclosure on file for jing zhang; no disclosure on file for Jing Zhang; no disclosure on file for Taiqiang Zhao

Relationship Between Endothelial Cell Protein C Receptor Gene 6936A/G Polymorphisms and Deep Venous Thrombosis.

Apolipoprotein E polymorphism is associated with lower extremity deep venous thrombosis: color-flow Doppler ultrasound evaluation

The Impact of Cardiovascular Disease Gene Polymorphism and Interaction with Homocysteine on Deep Vein Thrombosis

The association between EPCR gene p.Ser219Gly polymorphism and venous thromboembolism risk: a case-control study, meta-analysis, and a reproducibility study

Blood Cell Parameters Combined with Inflammatory Markers in the Early Diagnosis of Pulmonary Embolism

The protein C activity and cytochrome P4502C19 (CYP2C19) gene expression in the patients with acute deep vein thrombosis (DVT)

[Association of thrombospondin-1 gene N700S polymorphism with coronary artery disease].

Association of a single nucleotide polymorphism in PRKAA2 with deep vein thrombosis after orthopedic surgery

The incidence of the thrombophilic SNPs rs6025, rs1799963, rs2066865, rs2289252, and rs8176719 in chronic thromboembolic pulmonary hypertension

Influence of the 4G/5G polymorphism of plasminogen activator inhibitor-1 gene in acute unprovoked deep vein thrombosis and residual vein thrombosis

Genetic associations of protein-coding variants in venous thromboembolism

A Novel Variation of SERPINC1 Caused Deep Venous Thrombosis in a Chinese Family: A Case Report.

ASSOCIATION OF IMPACT FACTORS AND PREDICTIVE BIOMARKERS WITH HIGH RISK OF VENOUS THROMBOEMBOLISM IN HOSPITALIZED PATIENTS WITH ACUTE EXACERBATION OF COPD

Analysis of the association between an insertion/deletion polymorphism within the 3' untranslated region of COL1A2 and chronic venous insufficiency

Recent progress of gene polymorphisms in the formation of venous thromboembolism in different ethnic groups

Risk Factors Analysis in 617 Hospitalized Patients with Deep Venous Thromboembolism

[Study on the relationship between polymorphisms of susceptible genes in coagulation pathway related to pulmonary thromboembolism in Chinese Han population]

Genome-wide Association Analysis of Venous Thromboembolism Identifies New Risk Loci and Genetic Overlap with Arterial Vascular Disease

Identifying mutation‐driven changes in gene functionality that lead to venous thromboembolism

The Incidence of Pulmonary Embolism in Patients with Combined Lower Extremity Deep Venous Thrombosis and Iliac Vein Compression Syndrome

Association between FSAP 1601G > A polymorphism and venous thromboembolism risk: A meta-analysis.